Yield of Screening for Long-Term Complications Using the Children's Oncology Group Long-Term Follow-Up Guidelines

Journal of Clinical Oncology

Volumn 30, Issue 35, 2012, Pages 4401-4408

  Landier, Wendy ^a   Armenian, Saro H ^a   Lee, Jin ^a   Thomas, Ola ^a   Wong, F Lennie ^a   Francisco, Liton ^a   Herrera, Claudia ^a   Kasper, Clare ^a   Wilson, Karla D ^a   Zomorodi, Meghan ^a   Bhatia, Smita ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC ANTIMETABOLITE; BLEOMYCIN; BUSULFAN; CARBOPLATIN; CISPLATIN; CORTICOSTEROID; CREATININE; CYCLOPHOSPHAMIDE; DNA TOPOISOMERASE INHIBITOR; FERRITIN; IFOSFAMIDE; METHOTREXATE; NITROSOUREA;

ADOLESCENT; ARTICLE; AUDIOMETRY; BLADDER CANCER; BLOOD CELL COUNT; BONE DENSITY; CANCER SCREENING; CANCER SURVIVOR; CHILD; DUAL ENERGY X RAY ABSORPTIOMETRY; ELECTROCARDIOGRAM; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; HEARING IMPAIRMENT; HEMATURIA; HEMORRHAGIC CYSTITIS; HEPATITIS B; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HYPOTHYROIDISM; IRON OVERLOAD; KIDNEY FAILURE; KIDNEY INJURY; LEUKEMIA; LIVER TOXICITY; LOGISTIC REGRESSION ANALYSIS; LUNG DISEASE; LUNG FIBROSIS; LUNG FUNCTION TEST; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEINURIA; QT PROLONGATION; SCHOOL CHILD; SIDE EFFECT; SYSTOLIC DYSFUNCTION; THORAX RADIOGRAPHY; THYROID FUNCTION; UREA NITROGEN BLOOD LEVEL; URINALYSIS;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONG-TERM CARE; MALE; MIDDLE AGED; NEOPLASMS; SURVIVORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84870737034     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.43.4951     Document Type: Article

References (80)

1. Oeffinger KC, Mertens AC, Sklar CA, et al: Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 355:1572-1582, 2006 (Pubitemid 44547808)
2. Armenian SH, Meadows AT, Bhatia S: Late effects of childhood cancer and its treatment, in Pizzo PA, Poplack DG (eds): Principles and Practice of Pediatric Oncology (ed 6). Philadelphia, PA, Lippincott Raven, 2010, pp 1431-1462
3. Landier W, Bhatia S: Cancer survivorship: A pediatric perspective. Oncologist 13:1181-1192, 2008
4. Geenen MM, Cardous-Ubbink MC, Kremer LC, et al: Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA 297:2705-2715, 2007 (Pubitemid 47001096)
5. Diller L, Chow EJ, Gurney JG, et al: Chronic disease in the Childhood Cancer Survivor Study cohort: A review of published findings. J Clin Oncol 27:2339-2355, 2009
6. Hennekens CH, Buring JE: Screening, in Mayrent SL (ed): Epidemiology in Medicine. Boston, MA, Little, Brown and Company, 1987, pp 327-347
7. Hewitt M, Weiner SL, Simone JV: Childhood Cancer Survivorship: Improving Care and Quality of Life. Washington, DC, National Academies Press, 2003
8. Landier W, Bhatia S, Eshelman DA, et al: Development of risk-based guidelines for pediatric cancer survivors: The Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. J Clin Oncol 22:4979-4990, 2004 (Pubitemid 46638624)
9. Schwartz GJ, Furth SL: Glomerular filtration rate measurement and estimation in chronic kidney disease. Pediatr Nephrol 22:1839-1848, 2007 (Pubitemid 47506223)
10. Pierrat A, Gravier E, Saunders C, et al: Predicting GFR in children and adults: A comparison of the Cockcroft-Gault, Schwartz, and modification of diet in renal disease formulas. Kidney Int 64:1425-1436, 2003 (Pubitemid 37153809)
11. Beetham R, Cattell WR: Proteinuria: Pathophysiology, significance and recommendations for measurement in clinical practice. Ann Clin Biochem 30:425-434, 1993 (Pubitemid 23282371)
12. Kersun LS, Wimmer RS, Hoot AC, et al: Secondary malignant neoplasms of the bladder after cyclophosphamide treatment for childhood acute lymphocytic leukemia. Pediatr Blood Cancer 42:289-291, 2004 (Pubitemid 38235084)
13. McIntosh S, Davidson DL, O'Brien RT, et al: Methotrexate hepatotoxicity in children with leukemia. J Pediatr 90:1019-1021, 1977
14. Bianchetti MG, Kanaka C, Ridolfi-Lüthy A, et al: Persisting renotubular sequelae after cisplatin in children and adolescents. Am J Nephrol 11:127-130, 1991
15. Aoki Y, Belin RM, Clickner R, et al: Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002). Thyroid 17:1211-1223, 2007
16. Chang KW, Chinosornvatana N: Practical grading system for evaluating cisplatin ototoxicity in children. J Clin Oncol 28:1788-1795, 2010
17. Kreisman H, Wolkove N: Pulmonary toxicity of antineoplastic therapy. Semin Oncol 19:508-520, 1992
18. Kaste SC: Bone-mineral density deficits from childhood cancer and its therapy: A review of at-risk patient cohorts and available imaging methods. Pediatr Radiol 34:373-378, 2004; quiz 443-444
19. Knovich MA, Storey JA, Coffman LG, et al: Ferritin for the clinician. Blood Rev 23:95-104, 2009
20. Bath LE, Wallace WH, Critchley HO: Late effects of the treatment of childhood cancer on the female reproductive system and the potential for fertility preservation. BJOG 109:107-114, 2002 (Pubitemid 37338030)
21. Sklar C: Reproductive physiology and treatment-related loss of sex hormone production. Med Pediatr Oncol 33:2-8, 1999
22. Saslow D, Boetes C, Burke W, et al: American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57:75-89, 2007 (Pubitemid 46535708)
23. Motosue MS, Zhu L, Srivastava K, et al: Pulmonary function after whole lung irradiation in pediatric patients with solid malignancies. Cancer 118:1450-1456, 2012
24. Inaba H, Yang J, Pan J, et al: Pulmonary dysfunction in survivors of childhood hematologic malignancies after allogeneic hematopoietic stem cell transplantation. Cancer 116:2020-2030, 2010
25. Wasilewski-Masker K, Mertens AC, Patterson B, et al: Severity of health conditions identified in a pediatric cancer survivor program. Pediatr Blood Cancer 54:976-982, 2010
26. Mulder RL, Thönissen NM, van der Pal HJ, et al: Pulmonary function impairment measured by pulmonary function tests in long-term survivors of childhood cancer. Thorax 66:1065-1071, 2011
27. Weiner DJ, Maity A, Carlson CA, et al: Pulmonary function abnormalities in children treated with whole lung irradiation. Pediatr Blood Cancer 46:222-227, 2006 (Pubitemid 43076073)
28. Kaplan E, Sklar C, Wilmott R, et al: Pulmonary function in children treated for rhabdomyosarcoma. Med Pediatr Oncol 27:79-84, 1996 (Pubitemid 26198773)
29. Chotsampancharoen T, Gan K, Kasow KA, et al: Iron overload in survivors of childhood leukemia after allogeneic hematopoietic stem cell transplantation. Pediatr Transplant 13:348-352, 2009
30. Kornreich L, Horev G, Yaniv I, et al: Iron overload following bone marrow transplantation in children: MR findings. Pediatr Radiol 27:869-872, 1997 (Pubitemid 27494164)
31. McKay PJ, Murphy JA, Cameron S, et al: Iron overload and liver dysfunction after allogeneic or autologous bone marrow transplantation. Bone Marrow Transplant 17:63-66, 1996 (Pubitemid 26031892)
32. Kaste SC, Shidler TJ, Tong X, et al: Bone mineral density and osteonecrosis in survivors of childhood allogeneic bone marrow transplantation. Bone Marrow Transplant 33:435-441, 2004 (Pubitemid 38313094)
33. Kaste SC, Ahn H, Liu T, et al: Bone mineral density deficits in pediatric patients treated for sarcoma. Pediatr Blood Cancer 50:1032-1038, 2008 (Pubitemid 351506356)
34. Holzer G, Krepler P, Koschat MA, et al: Bone mineral density in long-term survivors of highly malignant osteosarcoma. J Bone Joint Surg Br 85:231-237, 2003 (Pubitemid 36410546)
35. Lewis MJ, DuBois SG, Fligor B, et al: Ototoxicity in children treated for osteosarcoma. Pediatr Blood Cancer 52:387-391, 2009
36. Schell MJ, McHaney VA, Green AA, et al: Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation. J Clin Oncol 7:754-760, 1989 (Pubitemid 19145597)
37. Macdonald MR, Harrison RV, Wake M, et al: Ototoxicity of carboplatin: Comparing animal and clinical models at the Hospital for Sick Children. J Otolaryngol 23:151-159, 1994 (Pubitemid 24238760)
38. Li Y, Womer RB, Silber JH: Predicting cisplatin ototoxicity in children: The influence of age and the cumulative dose. Eur J Cancer 40:2445-2451, 2004 (Pubitemid 39424959)
39. Kushner BH, Budnick A, Kramer K, et al: Ototoxicity from high-dose use of platinum compounds in patients with neuroblastoma. Cancer 107:417-422, 2006 (Pubitemid 44036572)
40. Bhatia S, Ramsay NK, Bantle JP, et al: Thyroid abnormalities after therapy for Hodgkin's disease in childhood. Oncologist 1:62-67, 1996 (Pubitemid 126669373)
41. Baker KS, Ness KK, Weisdorf D, et al: Late effects in survivors of acute leukemia treated with hematopoietic cell transplantation: A report from the Bone Marrow Transplant Survivor Study. Leukemia 24:2039-2047, 2010
42. Bonato C, Severino RF, Elnecave RH: Reduced thyroid volume and hypothyroidism in survivors of childhood cancer treated with radiotherapy. J Pediatr Endocrinol Metab 21:943-949, 2008
43. Steffens M, Beauloye V, Brichard B, et al: Endocrine and metabolic disorders in young adult survivors of childhood acute lymphoblastic leukaemia (ALL) or non-Hodgkin lymphoma (NHL). Clin Endocrinol (Oxf) 69:819-827, 2008
44. Bailey HK, Kappy MS, Giller RH, et al: Time-course and risk factors of hypothyroidism following allogeneic hematopoietic stem cell transplantation (HSCT) in children conditioned with fractionated total body irradiation. Pediatr Blood Cancer 51:405-409, 2008
45. Miyoshi Y, Ohta H, Hashii Y, et al: Endocrinological analysis of 122 Japanese childhood cancer survivors in a single hospital. Endocr J 55:1055-1063, 2008
46. Nandagopal R, Laverdière C, Mulrooney D, et al: Endocrine late effects of childhood cancer therapy: A report from the Children's Oncology Group. Horm Res 69:65-74, 2008
47. Grewal S, Merchant T, Reymond R, et al: Auditory late effects of childhood cancer therapy: A report from the Children's Oncology Group. Pediatrics 125:e938-e950, 2010
48. Wasilewski-Masker K, Kaste SC, Hudson MM, et al: Bone mineral density deficits in survivors of childhood cancer: Long-term follow-up guidelines and review of the literature. Pediatrics 121:e705-e713, 2008
49. Liles A, Blatt J, Morris D, et al: Monitoring pulmonary complications in long-term childhood cancer survivors: Guidelines for the primary care physician. Cleve Clin J Med 75:531-539, 2008
50. Huang TT, Hudson MM, Stokes DC, et al: Pulmonary outcomes in survivors of childhood cancer: A systematic review. Chest 140:881-901, 2011
51. Tillmann V, Darlington AS, Eiser C, et al: Male sex and low physical activity are associated with reduced spine bone mineral density in survivors of childhood acute lymphoblastic leukemia. J Bone Miner Res 17:1073-1080, 2002 (Pubitemid 34535146)
52. Arikoski P, Komulainen J, Voutilainen R, et al: Reduced bone mineral density in long-term survivors of childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol 20:234-240, 1998 (Pubitemid 28280900)
53. Kaste SC, Jones-Wallace D, Rose SR, et al: Bone mineral decrements in survivors of childhood acute lymphoblastic leukemia: Frequency of occurrence and risk factors for their development. Leukemia 15:728-734, 2001 (Pubitemid 32492695)
54. Müller HL, Schneider P, Bueb K, et al: Volumetric bone mineral density in patients with childhood craniopharyngioma. Exp Clin Endocrinol Diabetes 111:168-173, 2003 (Pubitemid 36682056)
55. Benmiloud S, Steffens M, Beauloye V, et al: Long-term effects on bone mineral density of different therapeutic schemes for acute lymphoblastic leukemia or non-Hodgkin lymphoma during childhood. Horm Res Paediatr 74:241-250, 2010
56. NIH Consensus Development Panel on Osteoporosis Prevention Diagnosis and Therapy: Osteoporosis prevention, diagnosis, and therapy. JAMA 285:785-795, 2001
57. De Bruin ML, Sparidans J, van't Veer MB, et al: Breast cancer risk in female survivors of Hodgkin's lymphoma: Lower risk after smaller radiation volumes. J Clin Oncol 27:4239-4246, 2009
58. Floyd J, Mirza I, Sachs B, et al: Hepatotoxicity of chemotherapy. Semin Oncol 33:50-67, 2006 (Pubitemid 43214486)
59. Castellino S, Muir A, Shah A, et al: Hepatobiliary late effects in survivors of childhood and adolescent cancer: A report from the Children's Oncology Group. Pediatr Blood Cancer 54:663-669, 2010
60. Centers for Disease Control and Prevention: Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Recomm Rep 47:1-39, 1998
61. Locasciulli A, Testa M, Pontisso P, et al: Prevalence and natural history of hepatitis C infection in patients cured of childhood leukemia. Blood 90:4628-4633, 1997 (Pubitemid 27508470)
62. Aricò M, Maggiore G, Silini E, et al: Hepatitis C virus infection in children treated for acute lymphoblastic leukemia. Blood 84:2919-2922, 1994 (Pubitemid 24328079)
63. Cesaro S, Petris MG, Rossetti F, et al: Chronic hepatitis C virus infection after treatment for pediatric malignancy. Blood 90:1315-1320, 1997 (Pubitemid 27314171)
64. Castellino S, Lensing S, Riely C, et al: The epidemiology of chronic hepatitis C infection in survivors of childhood cancer: An update of the St Jude Children's Research Hospital hepatitis C seropositive cohort. Blood 103:2460-2466, 2004 (Pubitemid 38392994)
65. Ly KN, Xing J, Klevens RM, et al: The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Ann Intern Med 156:271-278, 2012
66. Gerl A, Mühlbayer D, Hansmann G, et al: The impact of chemotherapy on Leydig cell function in long term survivors of germ cell tumors. Cancer 91:1297-1303, 2001 (Pubitemid 32267041)
67. Greenfield DM, Walters SJ, Coleman RE, et al: Prevalence and consequences of androgen deficiency in young male cancer survivors in a controlled cross-sectional study. J Clin Endocrinol Metab 92:3476-3482, 2007 (Pubitemid 47435323)
68. Romerius P, Ståhl O, Moëll C, et al: Hypogonadism risk in men treated for childhood cancer. J Clin Endocrinol Metab 94:4180-4186, 2009
69. Ridola V, Fawaz O, Aubier F, et al: Testicular function of survivors of childhood cancer: A comparative study between ifosfamide- and cyclophosphamide-based regimens. Eur J Cancer 45:814-818, 2009
70. Bhatia S, Yasui Y, Robison LL, et al: High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: Report from the Late Effects Study Group. J Clin Oncol 21:4386-4394, 2003 (Pubitemid 46621816)
71. Bassal M, Mertens AC, Taylor L, et al: Risk of selected subsequent carcinomas in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. J Clin Oncol 24:476-483, 2006 (Pubitemid 46630467)
72. Jones DP, Chesney RW: Renal toxicity of cancer chemotherapeutic agents in children: Ifosfamide and cisplatin. Curr Opin Pediatr 7:208-213, 1995
73. Skinner R, Pearson AD, English MW, et al: Cisplatin dose rate as a risk factor for nephrotoxicity in children. Br J Cancer 77:1677-1682, 1998 (Pubitemid 28230473)
74. Brock PR, Koliouskas DE, Barratt TM, et al: Partial reversibility of cisplatin nephrotoxicity in children. J Pediatr 118:531-534, 1991
75. Stöhr W, Paulides M, Bielack S, et al: Nephrotoxicity of cisplatin and carboplatin in sarcoma patients: A report from the late effects surveillance system. Pediatr Blood Cancer 48:140-147, 2007 (Pubitemid 44958269)
76. Hudson MM, Rai SN, Nunez C, et al: Noninvasive evaluation of late anthracycline cardiac toxicity in childhood cancer survivors. J Clin Oncol 25:3635-3643, 2007 (Pubitemid 47372601)
77. Dodd RY: The risk of transfusion-transmitted infection. N Engl J Med 327:419-421, 1992
78. Lackritz EM, Satten GA, Aberle-Grasse J, et al: Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States. N Engl J Med 333:1721-1725, 1995 (Pubitemid 26007122)
79. Yuen MF, Lai CL: Treatment of chronic hepatitis B: Evolution over two decades. J Gastroenterol Hepatol 26:138-143, 2011 (suppl 1)
80. Camacho R, Teófilo E: Antiretroviral therapy in treatment-naive patients with HIV infection. Curr Opin HIV AIDS 6:S3-S11, 2011 (suppl 1)